S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
ASX:HVN

Harvey Norman (HVN) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
4.17 million shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
4.27%
Price Target
N/A
HVN stock logo

About Harvey Norman Stock (ASX:HVN)

Harvey Norman Holdings Limited engages in the integrated retail, franchise, property, and digital system businesses. It franchises and sells products in various categories, including electrical goods, furniture, computerized communications, bedding and Manchester, kitchen and small appliances, bathroom and tiles, and carpets and floorings. It operates complexes under the Harvey Norman, Domayne, and Joyce Mayne brands in Australia; and company-operated stores under the Harvey Norman brand in New Zealand, Singapore, Malaysia, Slovenia, Croatia, Ireland, and Northern Ireland. It is also involved in the property investment and media placement activities; acts as a lessor of premises to Harvey Norman, Domayne, and Joyce Mayne franchisees and other third parties, as well as retail properties; development and sale of properties; and provision of consumer finance and other commercial loans and advances. The company was founded in 1982 and is headquartered in Homebush West, Australia.

HVN Stock News Headlines

Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Tonya Harvey
Harvey Norman Holdings Ltd.
TPC Group Promotes John Harvey, III to Senior Vice President, Operations
See More Headlines
Receive HVN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Harvey Norman and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/28/2019
Ex-Dividend for 4/30 Dividend
4/01/2024
Today
4/19/2024
Dividend Payable
4/30/2024

Industry, Sector and Symbol

Industry
Specialty Retail
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
6,500
Year Founded
N/A

Profitability

Net Income
$373.63 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$2.78 billion
Book Value
A$3.59 per share

Miscellaneous

Outstanding Shares
1,250,000,000
Free Float
N/A
Optionable
Not Optionable
Beta
0.69
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

  • Mr. Gerald Harvey (Age 85)
    Co-Founder, Executive Chairman & Head of Strategy
    Comp: $775k
  • Ms. Kay Lesley Harvey Page (Age 67)
    CEO & Executive Director
    Comp: $2.95M
  • Mr. Chris Mentis F.C.A. (Age 58)
    FGIA, GradDipAppFin, Executive Director, CFO & Company Secretary
    Comp: $1.59M
  • Mr. John Evyn Slack-Smith (Age 55)
    Executive Director & COO
    Comp: $2.01M
  • Darren Salakas
    General Manager of Technology & Entertainment
  • Mr. Gordon Ian Dingwall
    Chief Information Officer
  • Mr. David Matthew Ackery (Age 64)
    Executive Director
    Comp: $2.01M
  • Mr. Thomas James Scott
    General Manager of Property
  • Emmanuel Hohlastos
    General Manager of Audio Visual
  • Richard Beaini
    General Manager of Audio Visual

HVN Stock Analysis - Frequently Asked Questions

How were Harvey Norman's earnings last quarter?

Harvey Norman Holdings Limited (ASX:HVN) announced its earnings results on Thursday, February, 28th. The company reported $0.20 earnings per share for the quarter, beating the consensus estimate of $0.18 by $0.02. Harvey Norman had a net margin of 13.43% and a trailing twelve-month return on equity of 8.47%.

How often does Harvey Norman pay dividends? What is the dividend yield for Harvey Norman?

Harvey Norman declared a Interim dividend on Thursday, March 28th. Shareholders of record on Tuesday, April 30th will be given a dividend of 0.10 per share on Tuesday, April 30th. This represents a dividend yield of 1.94%. The ex-dividend date is Monday, April 1st.
Read our dividend analysis for HVN
.

Is Harvey Norman a good dividend stock?

Harvey Norman (ASX:HVN) pays an annual dividend of A$0.22 per share and currently has a dividend yield of 4.27%. HVN has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 73.33%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for HVN.

What other stocks do shareholders of Harvey Norman own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Harvey Norman investors own include STMicroelectronics (STM), Harvey Norman (HNORY), a2 Milk (A2M), Vipshop (VIPS), Sydney Airport (SYD), Suncorp Group (SUN), Bravura Solutions (BVS), Australian Pharmaceutical Industries (API), ANZ Group (ANZBY) and ANZ Group (ANZ).

This page (ASX:HVN) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners